Novo Nordisk Just Gave Investors $16.5 Billion More Reasons to Get Excited

Danish pharmaceutical company Novo Nordisk (NYSE: NVO) just made the headlines for something other than Ozempic. Well, sort of. One of the company's subsidiaries, Novo Holdings, is responsible for deploying capital in a mission-driven, efficient way to help broaden Novo Nordisk's reach. Earlier…#danish #novonordisk #nvo #novoholdings #catalent #ozempic #ozempicand #belgium #indiana #wegovyandozempic
Source: Reuters: Health - Category: Consumer Health News Source Type: news